Mono Pharmacare Limited — Others, 24-03-2025: Trading Window

Mono Pharmacare Limited has announced a board meeting to address the closure of the trading window, which will be effective from April 1, 2025, until 48 hours after the declaration of the financial results for the year ended March 31, 2025. This step aligns with the company's code of conduct to manage insider trading among key personnel.

The closure of the trading window generally indicates heightened scrutiny around trading activities, which may affect share liquidity. Investors may view this as a protective measure, reflecting an intention to ensure transparency and compliance, potentially fostering a positive outlook for governance practices. However, it may also introduce short-term risks as trading opportunities diminish ahead of the financial results announcement.